<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>536</id><JournalTitle>DIFFERENTIATION OF STEM CELLS INTO PANCREATIC Î²-CELLS: REGENERATIVE MEDICINE FOR DIABETES</JournalTitle><Abstract>Diabetes mellitus is one of the major healthcare problems. Due to increase in occurrence of type I Diabetes and
complications in the current therapies there is a need to find an alternative therapy. Type I Diabetes is a result of autoimmune
destruction of insulin producing pancreatic beta cells. Thus, stem cell therapy which causes the replacement of those cells
would be appropriate, using in-vitro and in-vivo cell reprogramming from different cell sources. To develop such therapy an
understanding of the molecular mechanisms, transcriptional regulations and the signaling pathways during pancreas
development and morphogenesis is required. This review describes briefly about the genetic program underlying mouse
pancreas morphogenesis and new stem cell therapy developed for beta cell regeneration</Abstract><Email> neelam013@yahoo.co.in</Email><articletype>Research</articletype><volume>5</volume><issue>12</issue><year>2014</year><keyword>Pancreas development,Diabetes,Pancreatic Î²-cells,regenerative medicine</keyword><AUTHORS>Shaishavi Jansari,Nayan Devashri,Ankita Dhanani,Neelam Chauhan</AUTHORS><afflication>Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad,Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad,Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad,Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad</afflication></Article></Articles>